Three scientists were recognized by the Lasker Awards for their work on the GLP-1 hormone. Others were honored for work to ...

It’s a brain disease,” a prominent obesity doctor explained on a “60 Minutes” episode about the drugs. “Obesity is disease” ...

Air pollution, high temperatures, and risk factors such as obesity and high blood pressure are driving global increases in ...

Why Corbus Pharmaceuticals sees Novo Nordisk’s controversial approach to obesity drugs as a ticket to a blockbuster.

The results jibe with earlier research showing that childhood obesity rates are steadily rising, even though food insecurity ...

Severe obesity is already a significant problem for many children, especially since obese children often become obese adults. Could the now popular weight-loss injection drugs be a solution for those ...

BioAge Labs Inc., a clinical-stage biotechnology company developing therapies for obesity and metabolic disease, is seeking ...

Evidence shows that blockbuster weight-loss medications can reduce obesity even in children aged 6–11, but their long-term ...

Policymakers and health researchers are increasingly recognising the harms of stigmatising language and attitudes towards ...

Research in people with obesity or overweight has shown that long-term exercisers have belly fat with healthier properties ...

The release of early-stage data on three oral weight loss drug candidates hints at which companies have the strongest hand, ...

Exchange-traded funds, commonly known as ETFs, are security baskets where a collection of investments is pooled. Like stocks, ...